Cladribine Tablets in the ORACLE-MS Study Open-Label Maintenance Period: Analysis of Efficacy in Patients After Conversion to Clinically Definite Multiple Sclerosis (CDMS).

Giancarlo Comi, Thomas Leist, Mark S. Freedman, Bruce A. C. Cree, Patricia K. Coyle, Hans-Peter Hartung, Patrick Vermersch, Doris Damian, Fernando Dangond